Needham & Company LLC Boosts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $153.00
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective lifted by equities research analysts at Needham & Company LLC from $133.00 to $153.00 in a report released on ...
ETF Daily News29d
Needham & Company LLC Lowers Agilysys (NASDAQ:AGYS) Price Target to $125.00
Agilysys (NASDAQ:AGYS – Get Free Report) had its price target dropped by research analysts at Needham & Company LLC from $145.00 to $125.00 in a note issued to investors on Wednesday,Benzinga ...